All News
Medical Xpress / TikTok videos mislead on epilepsy care, experts say
Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a new study says.
Medical Xpress / GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk, research shows
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
Medical Xpress / The world is facing a cancer crisis that's hitting the most vulnerable hardest
When I worked on the latest Global Burden of Disease cancer study, a global project that tracks cancer patterns and deaths across countries, I found myself pausing as the numbers loaded on the screen. Even as a scientist ...
Tech Xplore / Setting the standard for more durable concrete
As infrastructure ages, one question shapes the future of cities: How do we know the materials we build with will last?
Medical Xpress / Liver cancer prevention, treatment efforts are working
Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among racial groups, a Cedars-Sinai Cancer study published in the journal Clinical Gastroenterology and Hepatology ...
Medical Xpress / Examining impact of federal relief program after major health care cyberattack
New research from the University of Minnesota School of Public Health provides the first detailed look at whether funding provided through a federal relief program effectively reached hospitals affected by a ransomware attack ...
Tech Xplore / People, not software, pose bigger risk to health care cybersecurity, says researcher
A new doctoral dissertation from the University of Vaasa, Finland, argues that health care cybersecurity will remain fragile unless technology, humans and organizational processes are treated as a single unified system. According ...
Medical Xpress / Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy. The azacitidine–venetoclax ...
Medical Xpress / New findings support a chemo-free approach for treating Ph+ ALL
A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial, which included adult ...
Medical Xpress / Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab in addition to the standard ...
Medical Xpress / Buying a gift for a loved one with cancer? Skip the fuzzy socks and give them meals or help with laundry instead
The season of gifting is in full swing—a time when people scour the internet and shops of all kinds for items that appropriately symbolize their relationships with their loved ones.
Medical Xpress / IV iron improves survival, increases hemoglobin in patients with iron-deficiency anemia and acute infection
Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, according to an analysis ...
